Developing Highly Signaling-Pathway Selective Molecules Using Mebias’ 19Fluid Platform
Time: 2:30 pm
day: Day One
Details:
- 19F NMR of native GPCRs in solution
- Conformation driven drug discovery to determine pathway selectivity
- Integrating pathway selectivity into drug discovery
